SeraCare Life Sciences divests biorepository business
“The sale of our Biorepository business is an important element in our growth strategy for SeraCare,” said Charles Mamrak, CEO of SeraCare. “We can now more freely serve our growing customer base in the in vitro diagnostics market and execute on our mission of improving quality of life by advancing a global understanding of disease.”
Most read news
Other news from the department business & finance
These products might interest you
Thermo Scientific TSX Universal Series Ultra-low Temperature Freezer by Thermo Fisher Scientific
Over 80 years of innovation packed into the next-generation ultra-low temperature freezer
The pinnacle of reliability, sustainability, and innovation
BioStore™ Automated Cryogenic Storage System by Azenta
Azenta's new BioStore Cryogenic Automated Sample Storage System with a Smaller Footprint
Get all the benefits of an automated cryogenic storage system that fits in your standard facility
Consumables & Instruments by Azenta
Azenta's Sample Consumables and Instruments
Improve sample tracking, ensure sample integrity, and drive process efficiency
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.